CUMC-Led Team Broadens Efforts to Understand Abnormalities Identified by Microarrays | GenomeWeb

Though recent studies have established chromosomal microarrays as a higher-yield tool for detecting constitutional abnormalities, geneticists continue to work to link copy number variations with specific phenotypes.

The US National Institute of Child Health and Human Development recently granted a team led by researchers from Columbia University Medical Center $5 million to better understand how variants uncovered by array analysis might be linked to developmental delay, structural abnormalities, and diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.